oxprenolol has been researched along with Cardiovascular Stroke in 34 studies
Oxprenolol: A beta-adrenergic antagonist used in the treatment of hypertension, angina pectoris, arrhythmias, and anxiety.
| Excerpt | Relevance | Reference |
|---|---|---|
| "473 patients with suspected acute myocardial infarction were entered into a randomised, double-blind, placebo-controlled comparison of disopyramide phosphate, 150 mg three times a day, and oxprenolol, 40 mg three times a day." | 9.05 | Randomised placebo-controlled trial comparing oxprenolol with disopyramide phosphate in immediate treatment of suspected myocardial infarction. ( Banks, DC; Hampton, JR; Mitchell, JR; Roland, JM; Rowley, JM; Wilcox, RG, 1980) |
| "The value of beta-blockade and of disopyramide phosphate in the immediate treatment of patients with suspected acute myocardial infarction was assessed in two placebo controlled trials." | 9.05 | Acute intervention studies in patients with myocardial infarction using atenolol, propranolol, oxprenolol and disopyramide phosphate. ( Wilcox, RG, 1981) |
| "In 736 patients, 24 hour electrocardiographic recordings were performed 14 to 36 days after acute myocardial infarction before the start of randomized treatment with 320 mg of slow release oxprenolol (n = 358) or placebo (n = 378)." | 9.05 | Effect of oxprenolol on ventricular arrhythmias: the European Infarction Study experience. ( Andresen, D; Bethge, KP; Boissel, JP; Peyrieux, JC; Schröder, R; Tietze, U; von Leitner, ER, 1985) |
| "Oxprenolol, a new beta-receptor blocking drug with intrinsic sympathomimetic activity, was used to treat 63 episodes of cardiac arrhythmia occurring in 43 patients with acute myocardial infarction or myocardial ischaemia." | 7.65 | Use of oxprenolol in cardiac arrhythmias associated with acute myocardial ischaemia. ( Pistevos, AC; Sandler, G, 1971) |
| "473 patients with suspected acute myocardial infarction were entered into a randomised, double-blind, placebo-controlled comparison of disopyramide phosphate, 150 mg three times a day, and oxprenolol, 40 mg three times a day." | 5.05 | Randomised placebo-controlled trial comparing oxprenolol with disopyramide phosphate in immediate treatment of suspected myocardial infarction. ( Banks, DC; Hampton, JR; Mitchell, JR; Roland, JM; Rowley, JM; Wilcox, RG, 1980) |
| "The value of beta-blockade and of disopyramide phosphate in the immediate treatment of patients with suspected acute myocardial infarction was assessed in two placebo controlled trials." | 5.05 | Acute intervention studies in patients with myocardial infarction using atenolol, propranolol, oxprenolol and disopyramide phosphate. ( Wilcox, RG, 1981) |
| "In 736 patients, 24 hour electrocardiographic recordings were performed 14 to 36 days after acute myocardial infarction before the start of randomized treatment with 320 mg of slow release oxprenolol (n = 358) or placebo (n = 378)." | 5.05 | Effect of oxprenolol on ventricular arrhythmias: the European Infarction Study experience. ( Andresen, D; Bethge, KP; Boissel, JP; Peyrieux, JC; Schröder, R; Tietze, U; von Leitner, ER, 1985) |
| "Oxprenolol, a new beta-receptor blocking drug with intrinsic sympathomimetic activity, was used to treat 63 episodes of cardiac arrhythmia occurring in 43 patients with acute myocardial infarction or myocardial ischaemia." | 3.65 | Use of oxprenolol in cardiac arrhythmias associated with acute myocardial ischaemia. ( Pistevos, AC; Sandler, G, 1971) |
| "Consecutive arrhythmias (ventricular pairs and runs of ventricular premature beats) and left-ventricular dysfunction alone were associated with a low mortality of 4." | 1.28 | Importance of quantitative analysis of ventricular arrhythmias for predicting the prognosis in low-risk postmyocardial infarction patients. European Infarction Study Group. ( Andresen, D; Bethge, KP; Boissel, JP; Peyrieux, JC; Schröder, R; Tietze, U; von Leitner, ER, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 33 (97.06) | 18.7374 |
| 1990's | 1 (2.94) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wilcox, RG | 2 |
| Rowley, JM | 1 |
| Hampton, JR | 3 |
| Mitchell, JR | 1 |
| Roland, JM | 1 |
| Banks, DC | 1 |
| Staessen, J | 1 |
| Bulpitt, C | 1 |
| Cattaert, A | 1 |
| Fagard, R | 1 |
| Vanhees, L | 1 |
| Amery, A | 1 |
| Weisswange, A | 1 |
| Frishman, WH | 2 |
| Furberg, CD | 2 |
| Friedewald, WT | 2 |
| Rose, G | 1 |
| Tuna, JL | 1 |
| Correia, MJ | 1 |
| d'Almeida, VC | 1 |
| Mourão, L | 1 |
| da Costa, FL | 1 |
| Ribeiro, C | 1 |
| Taylor, SH | 1 |
| Silke, B | 1 |
| Ebbutt, A | 1 |
| Sutton, GC | 1 |
| Prout, BJ | 1 |
| Burley, DM | 1 |
| Hausen, T | 1 |
| Walldius, G | 1 |
| Bühler, FR | 1 |
| Zilcher, H | 1 |
| Glogar, D | 1 |
| Fox, KM | 1 |
| Chopra, MP | 1 |
| Portal, RW | 1 |
| Aber, CP | 1 |
| Kaloianova, A | 1 |
| Beloev, I | 1 |
| Chaushev, A | 1 |
| Muiesan, G | 1 |
| Valori, C | 1 |
| Henning, H | 1 |
| Crawford, MH | 1 |
| Karliner, JS | 1 |
| O'Rourke, RA | 1 |
| Andresen, D | 2 |
| Bethge, KP | 2 |
| Boissel, JP | 2 |
| von Leitner, ER | 2 |
| Peyrieux, JC | 2 |
| Schröder, R | 3 |
| Tietze, U | 2 |
| Halawa, B | 1 |
| Mazurek, W | 1 |
| Gettes, LS | 1 |
| Singh, BN | 1 |
| Jewitt, DE | 1 |
| Myburgh, DP | 1 |
| Sandler, G | 1 |
| Pistevos, AC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Heart Rate Lowering Efficacy and Respiratory Safety of Ivabradine in Patients With Obstructive Airway Disease[NCT01365286] | Phase 4 | 40 participants (Actual) | Interventional | 2009-05-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
8 reviews available for oxprenolol and Cardiovascular Stroke
| Article | Year |
|---|---|
The use of beta blockers for the reduction of mortality after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Atenolol; Clinical Trials as Topic; Double-Blind Method; Fe | 1981 |
Beta-adrenergic blockade for survivors of acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Coron | 1984 |
The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Atenolol; Clinical Trials as Topic; Humans | 1984 |
Presentation and analysis of the results of clinical trials in cardiovascular disease.
Topics: Aspirin; Clinical Trials as Topic; Disopyramide; Home Care Services; Hospitalization; Humans; Myocar | 1981 |
Beta-blockade withdrawal.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Clinical Trials as Topic; Humans; Myocardial Infarctio | 1975 |
[Effect of beta-adrenolytic drugs on the survival of patients after myocardial infarction].
Topics: Adrenergic beta-Antagonists; Adult; Aftercare; Aged; Clinical Trials as Topic; Follow-Up Studies; Hu | 1986 |
Beta adrenergic blocking drugs in the treatment of cardiac arrhythmias.
Topics: Adrenergic beta-Antagonists; Alprenolol; Arrhythmia, Sinus; Arrhythmias, Cardiac; Atrial Fibrillatio | 1970 |
Beta-adrenergic receptor blocking drugs in cardiac arrhythmias.
Topics: Action Potentials; Adrenergic beta-Antagonists; Alprenolol; Arrhythmia, Sinus; Arrhythmias, Cardiac; | 1974 |
21 trials available for oxprenolol and Cardiovascular Stroke
| Article | Year |
|---|---|
Randomised placebo-controlled trial comparing oxprenolol with disopyramide phosphate in immediate treatment of suspected myocardial infarction.
Topics: Acute Disease; Adult; Aged; Arrhythmias, Cardiac; Blood Pressure; Clinical Trials as Topic; Disopyra | 1980 |
The use of beta blockers for the reduction of mortality after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Atenolol; Clinical Trials as Topic; Double-Blind Method; Fe | 1981 |
Acute intervention studies in patients with myocardial infarction using atenolol, propranolol, oxprenolol and disopyramide phosphate.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Clinical Trials as Topic; Disopyramide; Double-B | 1981 |
Secondary prevention with beta-adrenoceptor blockers in post-myocardial infarction patients.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Double-Blind Method; Humans; Metoprolol; Myoc | 1982 |
[Improved prognosis using beta blockers after myocardial infarct?].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Clinical Trials as Topic; Female; Humans; Male; Metoprolol | 1984 |
Beta-adrenergic blockade for survivors of acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Coron | 1984 |
The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Atenolol; Clinical Trials as Topic; Humans | 1984 |
Procainamide, oxprenolol and amiodarone as antidysrhythmic drugs in myocardial infarction.
Topics: Amiodarone; Benzofurans; Cardiac Complexes, Premature; Clinical Trials as Topic; Death, Sudden; Doub | 1980 |
European Infarction Study (E.I.S.). A secondary prevention study with slow release oxprenolol after myocardial infarction: morbidity and mortality.
Topics: Adult; Aged; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Europe; Fem | 1984 |
A long-term prevention study with oxprenolol in coronary heart disease.
Topics: Adult; Aged; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Humans; Male; Middle A | 1982 |
European infarction study (EIS). A secondary prevention study with slow release oxprenolol after myocardial infarction.
Topics: Adult; Aged; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Electrocard | 1982 |
An early intervention secondary prevention study with oxprenolol following myocardial infarction.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Myoca | 1981 |
Beta-blockade withdrawal.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Clinical Trials as Topic; Humans; Myocardial Infarctio | 1975 |
Anti-dysrhythmic treatment in acute myocardial infarction.
Topics: Acute Disease; Administration, Oral; Atenolol; Clinical Trials as Topic; Disopyramide; Double-Blind | 1979 |
[Changes in myocardial contractile function and in the hemodynamic indices in patients with myocardial infarct before and after beta-blockader treatment].
Topics: Acute Disease; Adult; Aged; Clinical Trials as Topic; Drug Evaluation; Female; Heart Rate; Hemodynam | 1978 |
Effect of oxprenolol on ventricular arrhythmias: the European Infarction Study experience.
Topics: Adult; Aged; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Clinical Trials as Topic; Delayed-A | 1985 |
Myocardial infarctions and cerebrovascular accidents in relation to blood pressure control. The IPPPSH Collaborative Group.
Topics: Adult; Cerebrovascular Disorders; Death, Sudden; Double-Blind Method; Female; Humans; Hypertension; | 1985 |
Cardiovascular risk and risk factors in a randomized trial of treatment based on the beta-blocker oxprenolol: the International Prospective Primary Prevention Study in Hypertension (IPPPSH). The IPPPSH Collaborative Group.
Topics: Adult; Blood Pressure; Cardiovascular Diseases; Cerebrovascular Disorders; Clinical Trials as Topic; | 1985 |
Oxprenolol in myocardial infarction survivors: brief review of the European Infarction Study results in the light of other beta-blocker post infarction trials.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Animals; Arrhythmias, Cardiac; Clinical Trials as Topic; D | 1985 |
[Effect of beta-adrenolytic drugs on the survival of patients after myocardial infarction].
Topics: Adrenergic beta-Antagonists; Adult; Aftercare; Aged; Clinical Trials as Topic; Follow-Up Studies; Hu | 1986 |
Oxprenolol and ventricular ectopic activity of the heart.
Topics: Arrhythmias, Cardiac; Attitude to Health; Clinical Trials as Topic; Humans; Myocardial Infarction; O | 1974 |
10 other studies available for oxprenolol and Cardiovascular Stroke
| Article | Year |
|---|---|
Beta-blockers after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Humans; Myocardial Infarction; Oxprenolol; Propranolol; Timolol | 1984 |
[Withdrawal syndrome following beta blocker therapy (author's transl)].
Topics: Adult; Angina Pectoris; Atenolol; Chlorthalidone; Female; Humans; Hypertension; Middle Aged; Myocard | 1981 |
What happens after lipoprotein lipase? A low fatty acid incorporation into adipose tissue (FIAT) in hypertriglyceridaemia-experimental and clinical studies.
Topics: Adipose Tissue; Adult; Aged; Clofibrate; Fatty Acids; Glucose; Humans; Lipolysis; Lipoprotein Lipase | 1981 |
[Essential hypertension: adrenergic control system, renin-angiotensin effector axis, kidney and age].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aging; Angiotensin II; Catecholamines; Diuretics; Humans; | 1976 |
[Non arrhythmogenic sudden death as complication of coronary heart disease].
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Coronary Artery Bypass; Coronary Disease; Death, | 1979 |
Long-term beta blockade: possible protection from myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aspartate Aminotransferases; Blood Sedimentation; Body Temperature; Cor | 1975 |
[Sympathetic nervous activity and ischemic cardiopathy].
Topics: Aged; Angina Pectoris; Catecholamines; Coronary Disease; Heart Failure; Humans; Male; Middle Aged; M | 1977 |
Beneficial effects of nitroglycerin on abnormal ventricular wall motion at rest and during exercise in patient with previous myocardial infarction.
Topics: Adult; Aged; Drug Therapy, Combination; Heart Ventricles; Hemodynamics; Humans; Hypertension; Male; | 1976 |
Importance of quantitative analysis of ventricular arrhythmias for predicting the prognosis in low-risk postmyocardial infarction patients. European Infarction Study Group.
Topics: Arrhythmias, Cardiac; Electrocardiography; Electrocardiography, Ambulatory; Female; Follow-Up Studie | 1990 |
Use of oxprenolol in cardiac arrhythmias associated with acute myocardial ischaemia.
Topics: Adult; Aged; Arrhythmias, Cardiac; Humans; Middle Aged; Myocardial Infarction; Oxprenolol | 1971 |